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Objective: We aim to evaluate and describe the tissue
elasticity characteristics of various ovarian lesions with
sonoelastography.
Methods: 35 patients (age range 16–85 years; mean age
40.8 years) underwent sonoelastography and later MRI.
Histopathological confirmation of all lesions was carried out,
except eight of endometriomas and six of septated cysts
which were confirmed on MRI and follow-up ultrasonogra-
phy. Strain ratios and elastogram patterns were recorded.
Lesions were classified into three groups (Group 1: cystic
lesions, Group 2: benign tumours and Group 3: malignant
lesions) and findings were compared between groups for
both observers. Interobserver agreement was analyzed.
Optimal cut-off values for strain ratios were achieved with
receiver operating characteristic curve analysis.
Results: Ovarian endometriomas and complex cystic
lesions were observed hard on elastograms with high
strain ratios, and malignant lesions were observed mostly
soft with very small strain ratios. Benign tumours had
average tissue stiffness, observed harder than the
malignant lesions, and strain ratios ranged from 4 to
14. The differences in patterns and strain ratios between
groups were statistically significant (p,0.05 for both
observers).
Conclusion: Our study revealed that malignant ovarian
lesions have softer tissue property than benign lesions
and cystic lesions in terms of elastogram patterns and
strain ratios.
Advances in knowledge: Most ovarian lesions contain
solid and cystic parts which make the malignant and
benign lesions look similar on imaging modalities. Using
real-time sonoelastography as an adjunct to other
imaging modalities may improve the differentiation of
malignant ovarian lesions from benign lesions.
INTRODUCTION
Ovarian lesions have various imaging characteristics as
being purely cystic, solid or cystic lesions with solid com-
ponents.1 Some cystic lesions are complex cysts with sep-
tations, haemorrhage or thick walls. Malignant lesions have
different imaging characteristics as being pure solid or
having solid and cystic components together. Differentia-
tion between benign and malignant lesions is challenging
in ovaries. First-line imaging tool is ultrasonography, either
transabdominal or transvaginal.1,2 According to the clas-
sification of the International Ovarian Tumour Analysis
Group, solid lesions or multilocular cysts with solid com-
ponent have the highest risk of malignancy.2 Imaging with
conventional greyscale ultrasonography, Doppler ultraso-
nography and/or MRI is important for diagnosis before
deciding about surgery.1 It is reported that subjective
evaluation of greyscale ultrasonography characteristics,
colour and power Doppler imaging and three-dimensional
Doppler imaging characteristics of the ovarian malignant
and benign lesions might differ, and each modality has
some advantages over the other.3,4 Benign and malignant
masses of the ovary were proved to have vascularity but
resistive index, pulsatility index or temporal average mean
velocity measurements did not show specific changes in the
differential diagnosis.5 In a recent study, Doppler ultraso-
nography alone was shown to have a sensitivity of 71.88%
and specificity of 84.28% in the identification of ovarian
malignancies.6 MRI is advantageous because it provides
multiplanar imaging, high-contrast resolution and tissue
differentiation. It is also important in characterization of
biochemical states of blood and fat component that may
exist in the lesions of ovaries.7 Besides these advantages and
its high spatial and contrast resolution, MRI has dis-
advantages of being more expensive than other modalities
and requires longer imaging times. The need for contrast
material usage that can end up with nephrogenic systemic
fibrosis is another downside of MRI. Sonoelastography is
a novel technique for assessing tissue stiffness which is
recently being used for differentiation between malignant
and benign lesions of the breast and thyroid.8–11 We
thought that elastography property which is recently being
adjusted to most of the high-quality ultrasonography scan-
ners can also be used in the evaluation of ovarian masses. As
shown in thyroid or breast lesions, elasticity characteristics of
the ovarian lesions may also be used in the differentiation of
malignant and benign lesions. Because almost all patients with
pelvic complaints undergo ultrasonography examinations,
use of elastography is easy by just switching the scanner into
elastography mode. We thought that if any elastographic
pattern characteristics could be established, it would be a cost-
effective approach to the management of patients with ovarian
lesions by preventing most of the patients from undergoing
unnecessary MRI, and it would add much more information
to the greyscale and colour Doppler ultrasonography evalu-
ation of the lesions. Therefore in this study, we aimed to
evaluate various ovarian lesions with real-time strain elastog-
raphy (RTSE) and tried to describe the tissue elasticity charac-
teristics of malignant and benign ovarian masses. To the best of
our knowledge, there is no study in the literature which eval-
uates the tissue elasticity of different ovarian masses with
sonoelastography.
METHODS AND MATERIALS
Study population, equipment and scanning
This study was approved by the local ethics committee.
33 patients (age range 16–85 years; mean age 40.8 years) were
enrolled consecutively in this study. All patients presented with
right or left lower quadrant pain, pelvic fullness, vaginal dis-
charge or menstrual irregularities. Written informed consent
was obtained before the examinations. Patients who were
overweight and obese were excluded from the study because
effective compression to create a colour-coded map of the mass
was not possible in these patients. Also, patients who had small
follicular cysts or simple dominant follicles in the ovaries or
diagnosed with polycystic ovarian syndrome and did not un-
dergo MRI were excluded from the study. Patients with complex
ovarian masses to which effective compression was available by
transabdominal sonographic approach were included in this
study. The final diagnoses were endometrioma (n5 10), sep-
tated complex cyst (n5 4), dermoid cyst (n5 3), mature cystic
teratoma (n5 2), immature teratoma (n5 1), mucinous cys-
tadenoma (n5 2), sclerosing stromal tumour (SST) (n5 2),
Krukenberg tumour (n5 1), granulocytic sarcoma (n5 1),
Brenner tumour (n5 2), high-grade serous adenocarci-
noma (n5 5).
Dermoid cysts, teratomas, Krukenberg tumour, granulocytic
sarcoma, Brenner tumours, SSTs, mucinous cystadenomas,
high-grade serous adenocarcinomas, six of the endometriomas
and one of the complex cyst were confirmed by means of his-
topathological examination. The rest of the endometriomas and
cysts were confirmed by their imaging characteristics on MRI
and monthly follow-up ultrasonography.
All patients included in the study underwent pelvic MRI that
was performed with a 1.5-T superconducting system (Signa™
Excite; GE Healthcare, Milwaukee, WI) using an eight-channel
phased-array torso coil. Axial T1 weighted three-dimensional
spoiled gradient echo pulse sequence with fat suppression before
and after gadolinium-based contrast material injection was
obtained. Also, axial T1 weighted gradient echo sequence with-
out fat suppression and axial and coronal T2 weighted fast spin
echo sequences were obtained. Subtraction MRI was also obtained.
Patients underwent transabdominal sonoelastographic exami-
nation with a sonographic scanner (LOGIQ™ E9; GE Health-
care) with an elastography-compatible 1- to 5-MHz convex
probe. None of the patients had transvaginal sonographic eval-
uation because a transvaginal transducer was not available. Two
different radiologists with 10 years’ experience in conventional
ultrasonography and 3 years’ experience in sonoelastography
who were blinded to each other’s measurements did the
examinations separately. They also did not know the histopa-
thology or the diagnosis on MRI. First conventional trans-
abdominal ultrasonography was performed and ovarian
lesions were located. Then, the scanner was switched into
elastographic mode. Greyscale sonogram and elastogram
images were displayed simultaneously in the dual mode. Local
strain was achieved by freehand technique with vertical
compressions–decompressions.12,13 The quality of compression
was indicated on a scale between 1 and 7 using a quality
feedback bar. At least five bars of the indicator should be active
for optimal compression. Tissue stiffness was displayed on
a colour-coded map where red areas indicate soft-tissue parts,
green areas indicate intermediate and blue areas indicate hard-
tissue parts.
Image analysis
All static images were recorded and stored in the local sonog-
raphy device for later review. Sonoelastograms were classified
into five colour-overlay patterns according to tissue hardness
explained by different authors in the literature.8,14,15 Colour
mapping was set as blue being the hardest and red being the
softest tissue parts. The five colour-overlay patterns were as
follows: Pattern 1: an absent or a very small hard area with
mostly soft-tissue parts seen as red and green, Pattern 2: green
areas representing intermediate tissue stiffness with hard-tissue
(blue) parts appearing less than 50%, Pattern 3: intermediate
tissue stiffness with hard-tissue parts appearing more than 50%,
Pattern 4: peripheral hard-tissue and central soft-tissue parts,
Pattern 5: lesion is entirely hard with blue areas appearing more
than 90%. Strain ratios for all the lesions were calculated. The
first region of interest (ROI) was placed on a reference tissue
part. Selection of the reference area is important in strain ratio
calculations. Therefore, we chose the softest area coded as red
(E1) neighbouring the lesion for standardized calculations. The
second ROI was placed on the lesion including the entire lesion
area (E2). Placement of ROIs was performed by the radiologists
during the examination of patients with sonoelastography. Strain
ratio (E2/E1) was automatically calculated by the scanner.
After sonoelastography, all patients underwent MRI. All MR
images were reviewed by one of the radiologist with 7 years’ ex-
perience in abdominal MRI. Endometrioma diagnosis was carried
out by specific characteristics such as hyperintense lesion on
unenhanced fat-saturated T1 weighted images, no enhancement
on T1 weighted subtraction images and T2 shading on T2 weighted
images seen as loss of signal intensity including, especially, the
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dependent layer of the cystic lesion. Complex septated cysts were
cystic lesions with septations and/or thick walls without gadoli-
nium enhancement on T1 weighted contrast-enhanced series.
Statistical analysis
The SPSS® v. 17.0 for Windows® software package (IBM Corp.,
New York, NY; formerly SPSS Inc., Chicago, IL) was used for
statistical data analysis. Data are presented as the mean6
standard error of mean. Differences between variables were
assessed by Kruskal Wallis and Mann–Whitney U tests. A p-value
of 0.05 or less was defined as significant. Diagnostic perfor-
mance of RTSE for each radiologist based on strain ratios was
also calculated using receiver operating characteristic (ROC)
curve analysis. The area under the ROC curve was categorized
as follows: ,0.60: worthless, 0.61–0.70: poor, 0.71–0.80:
fair, 0.81–0.90: good and 0.91–1.00: excellent. The elastogram
patterns were compared between the radiologists using the
weighted Cohen’s kappa coefficient (k). Intraclass correlation
coefficient with confidence interval of 95% was used to assess
the concordance between the radiologists in terms of strain
ratio measurements. Interobserver agreement was catego-
rized as follows: 0–0.20, poor; 0.21–0.40, fair; 0.41–0.60,
moderate; 0.61–0.80, substantial; and 0.81–1.00, almost
perfect.16
RESULTS
Mean strain ratio values and patterns of the lesions for both
observers were given in Table 1. According to the calculations,
cystic lesions were mostly Patterns 3, 4 and 5 showing hard-
tissue property. Malignant lesions were soft with Patterns 1 and
2, and strain ratios ranged between 1 and 4. Benign lesions with
solid and cystic parts (benign ovarian tumours) had different
tissue elasticity with cystic parts observed harder than their solid
component. Mostly Patterns 3 and 4 were observed, and strain
ratios ranged from 4 to 14 in these benign tumours. We also
classified the lesions into three groups as: Group 1 being benign
and entirely cystic without any solid components, Group 2 being
benign but having solid parts (pathologically proven benign
ovarian tumours) and Group 3 proven to be malignant by his-
topathological examination. Group 1 (n5 14) consisted of
septated cysts and endometriomas; Group 2 (n5 11) consisted
of dermoids, mucinous cystadenomas, Brenner tumours, SSTs
and mature cystic teratoma; and Group 3 (n5 8) consisted
of high-grade serous adenocarcinomas, immature teratoma,
Table 1. Distribution of strain ratios and elastogram patterns according to ovarian lesions for both observers
Diagnosis
Strain ratio Elastogram pattern
Observer 1 Observer 2 Observer 1 Observer 2
Endometrioma (n5 10) 9.536 0.60 9.246 0.60 4.56 0.17 4.66 0.22
Septated cysts (n5 4) 10.46 2.30 10.36 2.34 4.286 0.28 4.146 0.34
Dermoid cyst (n5 3) 46 1.74 3.86 1.74 2.336 1.15 2.336 1.15
Sclerosing stromal tumour (n5 2) 5.46 0.55 5.36 0.57 2.56 0.5 36 0.00
Mucinous cystadenoma (n5 2) 14.76 4.7 14.76 4.3 46 1.00 46 1.00
Brenner tumour (n5 2) 9.46 0.35 9.46 0.55 46 0.00 4.56 0.50
Mature cystic teratoma (n5 2) 11.86 4.8 12.16 4.9 4.56 0.50 4.56 0.50
Immature teratoma (n5 1) 5.8 5 3 3
Krukenberg tumour (n5 1) 1.27 1.17 1 1
Granulocytic sarcoma (n5 1) 1.5 1.3 2 1
High-grade serous adenocarcinoma (n5 5) 1.326 0.65 1.286 0.57 1.476 1.15 1.86 1.35
n, number of lesions.
Data presented as 6 standard error of mean.
Table 2. Comparison of mean strain ratios and elastogram patterns between groups for both observers
Groups
Strain ratios Elastogram patterns
Observer 1 Observer 2 Observer 1 Observer 2
Group 1 (n5 14) 9.86 0.84 9.596 0.84 4.46 0.19 4.46 0.14
Group 2 (n5 11) 8.66 1.59a 8.66 1.65a 3.36 0.36a 3.56 0.36a
Group 3 (n5 8) 2.486 0.65a,b 2.26 0.55a,b 1.866 1.1a,b 1.706 1.3a,b
n, number of lesions.
Data presented as 6 standard error of mean.
ap,0.05 compared with Group 1.
bp,0.05 compared with Group 2.
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granulocytic sarcoma and Krukenberg tumour. The mean of
the greatest diameters (mean6 standard error of mean) of
the lesions according to groups were 8.56 1 cm (range be-
tween 2.3 and 15 cm) for Group 1, 6.86 0.83 cm (range be-
tween 2.5 and 11.5 cm) for Group 2 and 9.56 1.4 cm (range
between 5 and 15 cm) for Group 3. There was statistically
significant difference in strain ratios and patterns between
Groups 1 and 3 for both observers (strain ratios: p5 0.01 and
0.008 for Observers 1 and 2, respectively, and elastogram
patterns: p5 0.004 for both observers). The findings between
Groups 1 and 2 were statistically significant for elastogram
patterns and strain ratios for both observers (elastogram pat-
terns: p5 0.010 and 0.028 for Observers 1 and 2, respectively,
and strain ratios: p5 0.004 and 0.01 for Observers 1 and 2,
respectively). Difference in strain ratios and elastogram patterns
were also statistically significant between Groups 2 and 3 (strain
ratios: p-value of 0.047 for Observer 1 and 0.046 for Observer 2,
respectively, and elastogram patterns: p5 0.043 and 0.041 for
Figure 1. Greyscale (a) and elastogram (b) images of a serous adenocarcinoma (white arrows) in the right ovary of a 58-year-old
female show Pattern 1. Placement of regions of interest is shown (c).
Figure 2. A 43-year-old female with histopathologically proven Brenner tumour (white arrows) in her left adnexal region. Greyscale
(a) and elastogram (b) show Pattern 4. After placement of the regions of interest (c, d), automatically derived strain ratio (E2/E1)
is 9.4.
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Observers 1 and 2, respectively). The findings among Groups 1,
2 and 3 are given in Table 2. Figures 1–4 provide examples of
different elastogram patterns of various ovarian lesions.
The concordance between the radiologists was substantial (k:
0.73, p, 0.001) for elastogram patterns and was excellent
(intraclass correlation coefficient: 0.97, p, 0.001) for strain
ratios for all ovarian lesions.
The ability of RTSE to differentiate between lesions was quan-
tified by ROC curve analysis. Area under the curve for differ-
entiation of complex cystic lesions (Group 1) from malignant
lesions (Group 3); benign tumours (Group 2) from malignant
tumours (Group 3); and benign tumours (Group 2) from
complex cystic lesions (Group 1) based on strain ratios was
calculated for each observer. Table 3 gives the optimal cut-off
values for strain ratios, and sensitivity and specificity values for
both observers.
DISCUSSION
This study reveals that unlike malignant lesions of other organs
such as the thyroid and breast which were reported as having
hard-tissue property on elastograms, tissue elasticity of ovarian
malignant lesions tends to be softer.17,18 The difference in tissue
elasticity is clearly observed between entirely cystic lesions and
solid malignant lesions. Benign tumours with solid and cystic
parts mostly showed intermediate tissue elasticity, especially
average tissue stiffness in their solid parts and increased tissue
stiffness seen as blue in their cystic parts on elastograms. The
elasticity differences in terms of pattern and strain ratio were
also statistically significant between benign and malignant
tumours (Groups 2 and 3).
Recently in a study carried out with transabdominal real-time
sonoelastography in high- and low-grade serous ovarian cancers,
high-grade lesions were found to be less stiff.14 This property
was reported to may be related with the necrosis within the
tumours. In our study, although serous carcinomas, granulocytic
sarcoma and Krukenberg tumour were pathologically reported
to have also necrosis, immature teratoma pathologically had
different immature and mature tissue parts with mucous glan-
dular structures but not necrosis. This pathological difference
was also reflected in the values of strain ratios and elastogram
patterns. Immature teratoma was pathologically grade 2 which
had strain ratios of 5.8 and 5 and Pattern 3 for both observers on
elastography. On the contrary, serous carcinomas, Krukenberg
tumour and granulocytic sarcoma had very low strain ratios
with elastogram patterns assigned as 1 and 2 (Table 1). There-
fore, these findings also showed us that necrosis might be the
reason that malignant lesions of the ovary had softer tissue
property on elastograms. Also, another study which was per-
formed with sonoelastography investigated the response of high-
Figure 3. Greyscale (a) and elastogram (b) images of a 29-year-old female show a complex ovarian cyst (white arrows) with thick
wall. Pattern 3 is observed on elastogram (b, d). Automatically derived strain ratio (E2/E1) is 8.3 (c, d).
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grade serous ovarian cancer to neoadjuvant chemotherapy
revealed that tumour got stiffer after the treatment.19 This also
shows that malignant ovarian lesions are soft on elastogram but
tissue stiffness increases after tumour treatment. Hence, benig-
nity and/or response to treatment in an ovarian lesion is pre-
sented as hard elastogram pattern and increased strain index.
According to our study benign ovarian tumours seem to have
higher stiffness than malignant lesions. Strain ratios of SSTs were
calculated as 5.3 and 5.4 for both observers with patterns repre-
senting average tissue stiffness, whereas Brenner tumours had
a strain ratio of 9.4, showing harder elastograms than SSTs (Table 1).
The differences in strain ratios and elastograms between benign
and malignant tumours were significant, and benign tumours have
harder tissue property than malignant lesions. Onur et al20 reported
that SST of an ovary had similar tissue stiffness as the myometrium
that demonstrated high stromal component in the tumour. We
also think that as the stromal component increases, tissue stiffness
increases on elastography in an ovarian tumour. In a study with
females who had polycystic ovarian syndrome, elastography revealed
higher strain ratios than that of the control group.15 They thought
that this change was also because of the hard stroma within the
ovaries affected by the disease. In the light of present knowledge, we
think that necrosis in an ovarian lesion causes low tissue elasticity
and more stromal component causes increased tissue stiffness.
In our study, both radiologists calculated almost similar strain
ratios for the lesions in all groups with an excellent concordance.
Figure 4. Greyscale (a) and elastogram (b) images of a 28-year-old female with endometrioma (white arrows) in her left ovary show
Pattern 5. After placement of regions of interest (c, d), automatically derived strain ratio (E2/E1) is 12.2. It was hyperintense on
unenhanced T1 weighted images, and no enhancement was seen on subtraction series on MRI.
Table 3. Receiver operating characteristic curve analysis with optimal cut-off values to differentiate lesions between groups based
on strain ratios
Parameter
Radiologist 1 Radiologist 2
Groups 1–2 Groups 1–3 Groups 2–3 Groups 1–2 Groups 1–3 Groups 2–3
Optimal cut-off (strain ratio) 7.9 6.5 5.3 7.7 6.5 5.2
Area under the curve 0.62 0.98 0.89 0.61 0.98 0.88
Sensitivity (%) 64 86 70 62 86 70
Specificity (%) 55 100 87 55 100 92
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Therefore, based on this fact, we tried to compare diagnostic
performance of RTSE in the evaluation of ovarian lesions by
using optimal cut-off value for strain ratios between each of the
three groups. According to our findings, complex cysts and
benign ovarian tumours may not be effectively distinguished
from each other by using strain ratios but malignant tumours
from benign tumours and complex cystic lesions can be effi-
ciently discriminated by using RTSE. Complex cysts of the ovary
contain septations, thick walls and sometimes haemorrhage and
mural nodules, and endometriomas also contain blood products
both of which are seen as complex lesions on ultrasonography.
Endometriomas are even seen as solid lesions on ultrasonogra-
phy because they are protean in their sonographic appearances
and overlap in imaging features of complex cystic lesions, and
benign and/or malignant lesions make these lesions difficult to
be distinguished from each other.21 Strain ratios and elastogram
patterns of the cystic lesions were observed to be similar to
benign tumours on RTSE in the current study, and RTSE
seemed to be ineffective in discriminating the lesions of Group 1
from the lesions in Group 2 according to the ROC analysis.
In different studies, determinant of tissue stiffness in cystic
lesions was reported to be caused by the fluid content itself.18,22
In simple breast cysts, an aliasing artefact as blue–green–red
(BGR) pattern was reported on elastography.23 In our study,
cystic lesions were not simple cysts; instead, they were mostly
endometriomas and septated cysts but did not contain solid
component. They had Patterns 4 and 5 on elastograms with very
high strain ratios representing hard-tissue property. Fluid con-
tent in an ovarian lesion appeared blue, representing increased
stiffness on elastograms in the current study. This showed us
that RTSE can be used as a promising tool in the differentiation
of cystic ovarian lesions from solid lesions where cysts would
have high tissue stiffness, appearing blue as observed in this
study. Studies with elastography in breast lesions already
reported that cysts had no elasticity appearing black or entirely
blue.24 According to our results, this characteristic also applies to
ovarian lesions where cysts and cystic component of the lesions
will appear hard. Sonoelastography is also reported to be used
for the obviation of some unnecessary diagnostic biopsies in
cystic lesions of the breast.14,25 We also think that RTSE could
prevent unnecessary MRI for ovarian lesions by differentiating
simple or complex cystic lesions from solid masses.
This study had some limitations. The first and main limitation is
that our sample population was small, but the number of
patients in all groups was at least close to each other. Second, we
had to use a scoring system adapted from different studies be-
cause of the lack of a widely accepted scoring criteria for elas-
tograms in ovarian lesions. We hope our study can be a guide for
further ovarian sonoelastography studies. Third, not all the
endometriomas and septated cysts had histopathological con-
firmation, but they are radiologically well recognized on MRI
and follow-up ultrasonography; therefore, we think that this
limitation can be ignored. Lastly, because of our technical
handicap, that is, because a transvaginal transducer was not
available on our scanner, we could not obtain transvaginal
evaluations of the lesions.
In conclusion, this study establishes that malignant lesions of
ovaries have soft-tissue characteristics on elastograms with very
low strain ratios. However, cystic lesions as endometriomas,
complex cysts or cystic parts of other lesions possess increased
tissue stiffness on elastograms. Benign tumours also have harder
tissue elasticity than malignant lesions. These results suggest that
RTSE can be an adjunct to other imaging methods in the dif-
ferentiation of malignant and benign ovarian lesions and might
reduce the costs resulting from unnecessary MRIs. As far as we
know, our study is the first RTSE study that included various
ovarian lesions, but more clinical observation and research with
sonoelastography should be conducted to prove the validity of
these findings.
REFERENCES
1. Choi JI, Park SB, Han BH, Kim YH, Lee YH,
Park HJ, et al. Imaging features of complex
solid and multicystic ovarian lesions: pro-
posed algorithm for differential diagnosis.
Clin Imaging 2016; 40: 46–56. doi: http://dx.
doi.org/10.1016/j.clinimag.2015.06.008
2. Dias DS, Bueloni-Dias FN, Delmanto A,
Tonon AF, Tayfour NM, Traiman P, et al.
Clinical management of incidental findings
on pelvic adnexal masses. Rev Assoc Med Bras
2015; 61: 469–73. doi: http://dx.doi.org/
10.1590/1806-9282.61.05.469
3. Jokubkiene L, Sladkevicius P, Valentin L.
Does three-dimensional power Doppler ul-
trasound help in discrimination between
benign and malignant ovarian masses? Ul-
trasound Obstet Gynecol 2007; 29: 215–25.
doi: http://dx.doi.org/10.1002/uog.3922
4. Guerriero S, Ajossa S, Risalvato A, Lai MP,
Mais V, Angiolucci M, et al. Diagnosis of
adnexal malignancies by using color Doppler
energy imaging as a secondary test in
persistent masses. Ultrasound Obstet Gynecol
1998; 11: 277–82. doi: http://dx.doi.org/
10.1046/j.1469-0705.1998.11040277.x
5. Tailor A, Jurkovic D, Bourne TH, Collins WP,
Campbell S. Sonographic prediction of
malignancy in adnexal masses using multi-
variate logistic regression analysis. Ultrasound
Obstet Gynecol 1997; 10: 41–7. doi: http://dx.
doi.org/10.1046/j.1469-
0705.1997.10010041.x
6. Zhang F, Zhang ZL. The diagnostic value of
transvaginal sonograph (TVS), color Dopp-
ler, and serum tumor marker CA125, CEA,
and AFP in ovarian cancer. Cell Biochem
Biophys 2015; 72: 353–7. doi: http://dx.doi.
org/10.1007/s12013-014-0463-x
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